Answers are grounded in this paper and cite their sources.
Background: Clinical research programs are often described from the perspective of academic departments with established infrastructure. In contrast, large private musculoskeletal practice networks face a different challenge: how to build a durable research structure while maintaining high-volume clinical operations, distributed leadership, and day-to-day practice efficiency.Objective: To describe an early-stage model for building a clinical research structure within a busy physician-led musculoskeletal practice network and to identify the operational, governance, and partnership strategies used to make research feasible in routine practice, including how physician decision-making authority over research was structured within a private equity–backed management services organization. Methods: This descriptive organizational case study drew on a 2024–2025 clinical research infrastructure assessment, including document review, semi-structured interviews with 12 UMP leaders, and two site visits, together with a structured, iterative review of internal strategic planning materials, leadership presentations, quality and patient-reported outcome (PRO) dashboards, and organizational documents from United Musculoskeletal Partners (UMP), interpreted against prior literature on orthopaedic research team development. Interpretations were checked through author consensus and face-validity review by market-level leaders.Results: UMP’s emerging model rests on five practical design choices: 1) starting with a focused research vision tied to patient outcomes and quality benchmarks; 2) placing physician leadership at the center of governance; 3) using external partners strategically to supplement internal capacity; 4) integrating research activities with existing clinical and operational workflows rather than creating a parallel academic structure; and 5) sequencing the work into short-term proof-of-concept projects and longer-term infrastructure building. Participation grew from a three-person founding team to 21 surgeons serving on a cross-site research council without additional compensation. Existing PRO infrastructure had captured 2,721,144 PRO scores by June 2026, with 2025 baseline compliance of 77.23% across participating practices.Conclusion: For high-volume musculoskeletal groups, durable research infrastructure may be most feasible when built as an extension of clinical operations rather than as a separate academic enterprise. A pragmatic, partnership-enabled, physician-led model may allow busy practice networks to generate publishable data, strengthen quality measurement, and create a sustainable pathway toward broader participation in innovation and clinical trials. Within a private equity–backed platform, documented governance preserved physician authority over research priorities, offering a counterexample to the assumption that such ownership necessarily limits physician direction of research.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: